SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-20-000012
Filing Date
2020-03-12
Accepted
2020-03-12 07:39:20
Documents
6
Period of Report
2020-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm 8-K 25806
2 EXHIBIT 99.1 a200312pirspr.htm EX-99.1 17891
3 a200312pirspr001.jpg GRAPHIC 318496
4 a200312pirspr002.jpg GRAPHIC 286205
5 a200312pirspr003.jpg GRAPHIC 216351
6 a200312pirspr004.jpg GRAPHIC 89296
  Complete submission text file 0001583648-20-000012.txt   1299031
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 20707173
SIC: 8731 Services-Commercial Physical & Biological Research